AAAAAA
Results: 1-25/105
Authors:
MAZIERE B
COENEN HH
Citation: B. Maziere et Hh. Coenen, PROCEEDINGS OF THE CONFERENCE ON PRECLINICAL PHARMACOLOGICAL STUDIES WITH AND FOR RADIOPHARMACEUTICALS - ORSAY, FRANCE - OCTOBER 24-25, 1996 - INTRODUCTION, Nuclear medicine and biology, 25(8), 1998, pp. 697-697
Authors:
CHARON Y
LANIECE P
TRICOIRE H
Citation: Y. Charon et al., RADIO-IMAGING FOR QUANTITATIVE AUTORADIOGRAPHY IN BIOLOGY, Nuclear medicine and biology, 25(8), 1998, pp. 699-704
Authors:
DELAFORGE M
Citation: M. Delaforge, IMPORTANCE OF METABOLISM IN PHARMACOLOGICAL STUDIES - POSSIBLE IN-VITRO PREDICTABILITY, Nuclear medicine and biology, 25(8), 1998, pp. 705-709
Authors:
DEPRE C
Citation: C. Depre, ISOLATED WORKING HEART - DESCRIPTION OF MODELS RELEVANT TO RADIOISOTOPIC AND PHARMACOLOGICAL ASSESSMENTS, Nuclear medicine and biology, 25(8), 1998, pp. 711-713
Authors:
HALL H
HALLDIN C
FARDE L
SEDVALL G
Citation: H. Hall et al., WHOLE HEMISPHERE AUTORADIOGRAPHY OF THE POSTMORTEM HUMAN BRAIN, Nuclear medicine and biology, 25(8), 1998, pp. 715-719
Authors:
HANTRAYE P
Citation: P. Hantraye, MODELING DOPAMINE SYSTEM DYSFUNCTION IN EXPERIMENTAL-ANIMALS, Nuclear medicine and biology, 25(8), 1998, pp. 721-728
Authors:
HUME SP
JONES T
Citation: Sp. Hume et T. Jones, POSITRON-EMISSION-TOMOGRAPHY (PET) METHODOLOGY FOR SMALL ANIMALS AND ITS APPLICATION IN RADIOPHARMACEUTICAL PRECLINICAL INVESTIGATION, Nuclear medicine and biology, 25(8), 1998, pp. 729-732
Authors:
MARZIN D
Citation: D. Marzin, PRECLINICAL EVALUATION OF RADIOPHARMACEUTICAL TOXICOLOGICAL PREREQUISITES, Nuclear medicine and biology, 25(8), 1998, pp. 733-736
Authors:
PLOUX L
MASTRIPPOLITO R
Citation: L. Ploux et R. Mastrippolito, IN-VIVO RADIOLABEL QUANTIFICATION IN SMALL-ANIMAL MODELS, Nuclear medicine and biology, 25(8), 1998, pp. 737-742
Authors:
OCONNOR WT
Citation: Wt. Oconnor, FUNCTIONAL NEUROANATOMY OF THE BASAL GANGLIA AS STUDIED BY DUAL-PROBEMICRODIALYSIS, Nuclear medicine and biology, 25(8), 1998, pp. 743-746
Authors:
OGREN SO
MISANE I
Citation: So. Ogren et I. Misane, ANIMAL-MODELS FOR STUDYING SEROTONIN (5-HT) RECEPTOR SUBTYPES - RELATIONSHIP TO 5-HT SYSTEM PATHOLOGIES, Nuclear medicine and biology, 25(8), 1998, pp. 747-749
Authors:
SNYDER SE
TLUCZEK L
JEWETT DM
NGUYEN TB
KUHL DE
KILBOURN MR
Citation: Se. Snyder et al., SYNTHESIS OF 1-[C-11]METHYLPIPERIDIN-4-YL PROPIONATE ([C-11]PMP) FOR IN-VIVO MEASUREMENTS OF ACETYLCHOLINESTERASE ACTIVITY, Nuclear medicine and biology, 25(8), 1998, pp. 751-754
Authors:
KILBOURN MR
NGUYEN TB
SNYDER SE
SHERMAN P
Citation: Mr. Kilbourn et al., N-[C-11]METHYLPIPERIDINE ESTERS AS ACETYLCHOLINESTERASE SUBSTRATES - AN IN-VIVO STRUCTURE-REACTIVITY STUDY, Nuclear medicine and biology, 25(8), 1998, pp. 755-760
SYNTHESES OF C-11 LABELED PIPERIDINE ESTERS AS POTENTIAL IN-VIVO SUBSTRATES FOR ACETYLCHOLINESTERASE
Authors:
NGUYEN TB
SNYDER SE
KILBOURN MR
Citation: Tb. Nguyen et al., SYNTHESES OF C-11 LABELED PIPERIDINE ESTERS AS POTENTIAL IN-VIVO SUBSTRATES FOR ACETYLCHOLINESTERASE, Nuclear medicine and biology, 25(8), 1998, pp. 761-768
Authors:
WILSON AA
INABA T
FISCHER N
DIXON LM
NOBREGA J
DASILVA JN
HOULE S
Citation: Aa. Wilson et al., DERIVATIVES OF WAY-100635 AS POTENTIAL IMAGING AGENTS FOR 5-HT1A RECEPTORS - SYNTHESES, RADIOSYNTHESES, AND IN-VITRO AND IN-VIVO EVALUATION, Nuclear medicine and biology, 25(8), 1998, pp. 769-776
Authors:
WECKESSER M
FIXMANN A
HOLSCHBACH M
MULLERGARTNER HW
Citation: M. Weckesser et al., INFLUENCE OF ACETYLCHOLINE ON BINDING OF 4-[I-125]IODODEXETIMIDE TO MUSCARINIC BRAIN RECEPTORS, Nuclear medicine and biology, 25(8), 1998, pp. 777-780
Authors:
VANDENBOS JC
RIJKS LJM
VANDOREMALEN PAPM
DEBRUIN K
JANSSEN AGM
VANROYEN EA
Citation: Jc. Vandenbos et al., NEW IODINATED PROGESTINS AS POTENTIAL LIGANDS FOR PROGESTERONE-RECEPTOR IMAGING IN BREAST-CANCER - PART 1 - SYNTHESIS AND IN-VITRO PHARMACOLOGICAL CHARACTERIZATION, Nuclear medicine and biology, 25(8), 1998, pp. 781-789
Authors:
RIJKS LJM
VANDENBOS JC
VANDOREMALEN PAPM
BOER GJ
DEBRUIN K
JANSSEN AGM
VANROYEN EA
Citation: Ljm. Rijks et al., NEW IODINATED PROGESTINS AS POTENTIAL LIGANDS FOR PROGESTERONE-RECEPTOR IMAGING IN BREAST-CANCER - PART 2 - IN-VIVO PHARMACOLOGICAL CHARACTERIZATION, Nuclear medicine and biology, 25(8), 1998, pp. 791-798
Authors:
SCHMALL B
CONTI PS
SCHAEFFER DJ
KLEINERT EL
Citation: B. Schmall et al., RADIOTRACER-DERIVED BIOCHEMICAL PROFILES VIA A MATHEMATICAL-MODEL - IMPLICATIONS FOR THERAPEUTIC INTERVENTION, Nuclear medicine and biology, 25(8), 1998, pp. 799-801
Authors:
WAKI A
FUJIBAYASHI Y
YOKOYAMA A
Citation: A. Waki et al., RECENT ADVANCES IN THE ANALYSES OF THE CHARACTERISTICS OF TUMORS ON FDG UPTAKE, Nuclear medicine and biology, 25(7), 1998, pp. 589-592
Authors:
WAKI A
KATO H
YANO R
SADATO N
YOKOYAMA A
ISHII Y
YONEKURA Y
FUJIBAYASHI Y
Citation: A. Waki et al., THE IMPORTANCE OF GLUCOSE-TRANSPORT ACTIVITY AS THE RATE-LIMITING STEP OF 2-DEOXYGLUCOSE UPTAKE IN TUMOR-CELLS IN-VITRO, Nuclear medicine and biology, 25(7), 1998, pp. 593-597
Authors:
HORTI AG
SCHEFFEL U
KOREN AO
RAVERT HT
MATHEWS WB
MUSACHIO JL
FINLEY PA
LONDON ED
DANNALS RF
Citation: Ag. Horti et al., 2-[F-18]FLUORO-A-85380, AN IN-VIVO TRACER FOR THE NICOTINIC ACETYLCHOLINE-RECEPTORS, Nuclear medicine and biology, 25(7), 1998, pp. 599-603
Authors:
MUKHERJEE J
DAS MK
YANG ZY
LEW R
Citation: J. Mukherjee et al., EVALUATION OF THE BINDING OF THE RADIOLABELED ANTIDEPRESSANT DRUG, F-18 FLUOXETINE IN THE RODENT BRAIN - AN IN-VITRO AND IN-VIVO STUDY, Nuclear medicine and biology, 25(7), 1998, pp. 605-610
Authors:
VANGOG FB
VISSER GWM
GOWRISING RWA
SNOW GB
VONDONGEN GAMS
Citation: Fb. Vangog et al., SYNTHESIS AND EVALUATION OF TC-99M TC-99-MAG3-BIOTIN CONJUGATES FOR ANTIBODY PRETARGETING STRATEGIES/, Nuclear medicine and biology, 25(7), 1998, pp. 611-619
Authors:
GUHLKE S
SCHAFFLAND A
ZAMORA PO
SARTOR J
DIEKMANN D
BENDER H
KNAPP FF
BIERSACK HJ
Citation: S. Guhlke et al., RE-188-MAG(3) AND TC-99M-MAG(3) AS PROSTHETIC GROUPS FOR LABELING AMINES AND PEPTIDES - APPROACHES WITH PRECONJUGATE AND POSTCONJUGATE LABELING, Nuclear medicine and biology, 25(7), 1998, pp. 621-631